Skip to content
Recall Observatory FDA recall evidence

Device product

Tosoh ST AIA-PACK HbA1c Pretreatment Solution, HbA1c Pretreatment Solution, PN 025718 The device is intended for In Vitro Diagnostic Use Only for the pretreatment of the patient samples or control set for the HbA1c assay

Z-1812-2018

March 05, 2018

Class II

Product summary

Firm
Tosoh Bioscience Inc
Event
Event 79708
Status
Terminated
Classification
Class II
Quantity
2258
Official record key
device-enforcement:Z-1812-2018

Official wording

Reason: The assay can potentially generate erroneously elevated or erroneously decreased HbA1c patient results.

Code information: All lots.

Distribution pattern: USA (nationwide) Distribution including PR and to the states of : AL, AR, AZ, CA, CO, CT, FL, GA, IA, ID, IL, KS, KY, LA, MA, MD, MI, MO, NC, NE, NV, NY, OH, OK, OR, PA, SC, SD, TN, TX, UT, VA, WA, WI, WV, and WY.

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    The assay can potentially generate erroneously elevated or erroneously decreased HbA1c patient results.